RNTX stock news · Rein Therapeutics, Inc.
Get alerts for RNTX
Follow Rein Therapeutics, Inc. (RNTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for RNTXFree on the App Store and Google Play, or on the web.
Rein Therapeutics shared early results from its Phase 2 trial, showing promise for lung health in patients.
NeutralRein Therapeutics said 8 of 24 patients had improved lung function after 12 weeks, but the blinded groups were combined. The report does not show whether its drug works.